Skip to main content
Anne Goldberg, MD, Endocrinology, Saint Louis, MO, Barnes-Jewish Hospital

AnneCarolGoldbergMD

Endocrinology Saint Louis, MO

Diabetes, Lipid Metabolism

Professor of Medicine, Washington University St Louis

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goldberg's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1977 - 1980
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1977

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1978 - 2026
  • MO State Medical License
    MO State Medical License 1981 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Cholesterol-Carrying Lipoproteins and Cardiovascular Risk: New Guidelines and Beyond 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Efficacy and Safety of Bempedoic Acid Added to Maximally Tolerated Statins in Patients with Hypercholesterolemia and High Cardiovascular Risk: The CLEAR Wisdom Trial 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • LDL-C and Beyond: Harnessing the Power of Novel Therapeutic Targets and Big Data to Improve Dyslipidemia Care 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Join now to see all

Press Mentions

  • Early Results Show Promise of an Oral PCSK9 Inhibitor
    Early Results Show Promise of an Oral PCSK9 InhibitorNovember 15th, 2021
  • Pooled Analyses Show NILEMDO®▼ Significantly Lowers Cholesterol in Different Subgroups in Phase 3 Data Presented at AHA 2020
    Pooled Analyses Show NILEMDO®▼ Significantly Lowers Cholesterol in Different Subgroups in Phase 3 Data Presented at AHA 2020November 16th, 2020
  • List of Temporary Practice Permits Granted May 5, 2020
    List of Temporary Practice Permits Granted May 5, 2020May 5th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations